# Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms

> **NCT06787066** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Missouri-Columbia** · enrollment: 75 (estimated)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Propranolol Hydrochloride
- **DRUG:** Phentolamine Injection

## Key facts

- **NCT ID:** NCT06787066
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06787066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06787066, "Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06787066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*